Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' WITTIG B' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 75 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Schakowski, F; Gorschluter, M; Junghans, C; Schroff, M; Buttgereit, P; Ziske, C; Schottker, B; Konig-Merediz, SA; Sauerbruch, T; Wittig, B; Schmidt-Wolf, IGH
      A novel minimal-size vector (MIDGE) improves transgene expression in coloncarcinoma cells and avoids transfection of undesired DNA

      MOLECULAR THERAPY
    2. Muller, J; Wittig, B; Sternkicker, H; Bendix, S
      Insights into the MOCVD process of GaN using single-source precursors. Matrix isolation: A powerful technique

      JOURNAL DE PHYSIQUE IV
    3. Muller, J; Wittig, B; Bendix, S
      Synthesis of monomeric Me2GaD via a beta-hydrogen elimination at high temperatures. A matrix-isolation study

      JOURNAL OF PHYSICAL CHEMISTRY A
    4. Wittig, B; Marten, A; Dorbic, T; Weineck, S; Min, H; Niemitz, S; Trojaneck, B; Flieger, D; Kruopis, S; Albers, A; Loffel, J; Neubauer, A; Albers, P; Muller, S; Sauerbruch, T; Bieber, T; Huhn, D; Schmidt-Wolf, IGH
      Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: A first clinical phase I/II trial

      HUMAN GENE THERAPY
    5. Schirmbeck, R; Konig-Merediz, SA; Riedl, P; Kwissa, M; Sack, F; Schroff, M; Junghans, C; Reimann, J; Wittig, B
      Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide

      JOURNAL OF MOLECULAR MEDICINE-JMM
    6. Marten, A; Ziske, C; Schottker, B; Weineck, S; Renoth, S; Buttgereit, P; Schakowski, F; Konig, S; von Rucker, A; Allera, A; Schroers, R; Sauerbruch, T; Wittig, B; Schmidt-Wolf, IGH
      Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs

      CANCER GENE THERAPY
    7. Nitsche, A; Becker, M; Junghahn, I; Aumann, J; Landt, O; Fichtner, I; Wittig, B; Siegert, W
      Quantification of human cells in NOD/SCID mice by duplex real-time polymerase-chain reaction

      HAEMATOLOGICA
    8. Micka, B; Trojaneck, B; Niemitz, S; Lefterova, P; Kruopis, S; Huhn, D; Wittig, B; Schadendorf, D; Schmidt-Wolf, IGH
      Comparison of non-viral transfection methods in melanoma cell primary cultures

      CYTOKINE
    9. Moller, P; Moller, H; Sun, YS; Dorbic, T; Henz, BM; Wittig, B; Schadendorf, D
      Increased non-major histocompatibility complex-restricted lytic activity in melanoma patients vaccinated with cytokine gene-transfected autologous tumor cells

      CANCER GENE THERAPY
    10. Ropke, G; Ebert, O; Marten, A; Lefterova, P; Micka, B; Buttgereit, P; Niemitz, S; Trojaneck, E; Schmidt-Wolf, G; von Rucker, A; Huhn, D; Wittig, B; Schmidt-Wolf, IGH
      Increase in proliferation rate and normalization of TNF-alpha secretion byblockage of gene transfer-induced apoptosis in lymphocytes using low-dose cyclosporine A

      CANCER GENE THERAPY
    11. Schmidt, M; Hochhaus, A; Konig-Merediz, SA; Brendel, C; Proba, J; Hoppe, GJ; Wittig, B; Ehninger, G; Hehlmann, R; Neubauer, A
      Expression of interferon regulatory factor 4 in chronic myeloid leukemia: Correlation with response to interferon alfa therapy

      JOURNAL OF CLINICAL ONCOLOGY
    12. Merediz, SAK; Zhang, EP; Wittig, B; Hoffmann, F
      Ballistic transfer of minimalistic immunologically defined expression constructs for IL4 and CTLA4 into the corneal epithelium in mice after orthotopic corneal allograft transplantation

      GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
    13. Merediz, SAK; Schmidt, M; Hoppe, GJ; Alfken, J; Meraro, D; Levi, BZ; Neubauer, A; Wittig, B
      Cloning of an interferon regulatory factor 2 isoform with different regulatory ability

      NUCLEIC ACIDS RESEARCH
    14. Boretti, FS; Leutenegger, CM; Mislin, C; Hofmann-Lehmann, R; Konig, S; Schroff, M; Junghans, C; Fehr, D; Huettner, SW; Habel, A; Flynn, JN; Aubert, A; Pedersen, NC; Wittig, B; Lutz, H
      Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression

      AIDS
    15. Blaheta, RA; Hailer, NP; Brude, N; Wittig, B; Leckel, K; Oppermann, E; Bachmann, M; Harder, S; Cinatl, J; Scholz, M; Bereiter-Hahn, J; Weber, S; Encke, A; Markus, BH
      In vitro analysis of verapamil-induced immunosuppression - Potent inhibition of T cell motility and lymphocytic transmigration through allogeneic endothelial cells

      TRANSPLANTATION
    16. Leutenegger, CM; Boretti, FS; Mislin, CN; Flynn, JN; Schroff, M; Habel, A; Junghans, C; Koenig-Merediz, SA; Sigrist, B; Aubert, A; Pedersen, NC; Wittig, B; Lutz, H
      Immunization of cats against feline immunodeficiency virus (FIV) infectionby using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, ora CpG motif

      JOURNAL OF VIROLOGY
    17. Ruiz-Ortega, M; Lorenzo, O; Ruperez, M; Konig, S; Wittig, B; Egido, J
      Angiotensin II activates nuclear transcription factor kappa B through AT(1) and AT(2) in vascular smooth muscle cells - Molecular mechanisms

      CIRCULATION RESEARCH
    18. Scholz, M; Blaheta, RA; Wittig, B; Cinatl, J; Vogel, JU; Doerr, HW; Cinatl, J
      Cytomegalovirus-infected neuroblastoma cells exhibit augmented invasiveness mediated by beta 1 alpha 5 integrin (VLA-5)

      TISSUE ANTIGENS
    19. Ebert, O; Ropke, G; Marten, A; Lefterova, P; Micka, B; Buttgereit, P; Niemitz, S; Trojaneck, B; Schmidt-Wolf, G; Huhn, D; Wittig, B; Schmidt-Wolf, IGH
      TNF-alpha secretion and apoptosis of lymphocytes mediated by gene transfer

      CYTOKINES CELLULAR & MOLECULAR THERAPY
    20. Wanner, R; Zober, A; Abraham, K; Kleffe, J; Henz, BM; Wittig, B
      Polymorphism at codon 554 of the human Ah receptor: different allelic frequencies in Caucasians and Japanese and no correlation with severity of TCDDinduced chloracne in chemical workers

      PHARMACOGENETICS
    21. Henze, G; Borgmann, A; von Stackelberg, A; Baumgarten, E; Uchanska-Ziegler, B; Ziegler, A; Wittig, B
      Immunotherapy of acute lymphoblastic leukemia by vaccination with autologous leukemic cells transected with a cDNA expression plasmid coding for an allogeneic HLA class I antigen combined with interleukin-2 treatment (vol 76, pg 215, 1998)

      JOURNAL OF MOLECULAR MEDICINE-JMM
    22. Wanner, R; Wolff, B; Glowacki, F; Kolde, G; Wittig, B
      The loss of desmosomes after retinoic acid treatment results in an apparent inhibition of HaCaT keratinocyte differentiation

      ARCHIVES OF DERMATOLOGICAL RESEARCH
    23. Blaheta, RA; Leckel, K; Wittig, B; Zenker, D; Oppermann, E; Harder, S; Scholz, M; Weber, S; Encke, A; Markus, BH
      Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4and CD8 T-cells

      TRANSPLANTATION PROCEEDINGS
    24. Wittig, B; Seiter, S; Schmidt, DS; Zuber, M; Neurath, M; Zoller, M
      CD44 variant isoforms on blood leukocytes in chronic inflammatory bowel disease and other systemic autoimmune diseases

      LABORATORY INVESTIGATION
    25. Stallmach, A; Wittig, B; Giese, T; Pfister, K; Hoffmann, JC; Bulfone-Paus, S; Kunzendorf, U; Meuer, SC; Zeitz, M
      Protection of trinitrobenzene sulfonic acid-induced colitis by an interleukin 2-IgG2b fusion protein in mice

      GASTROENTEROLOGY
    26. Schmidt-Wolf, IGH; Finke, S; Trojaneck, B; Denkena, A; Lefterova, P; Schwella, N; Heuft, HG; Prange, G; Korte, M; Takeya, M; Dorbic, T; Neubauer, A; Wittig, B; Huhn, D
      Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma

      BRITISH JOURNAL OF CANCER
    27. MULLER J; WITTIG B
      THE FORMATION OF HALX2 (X = CL, BR) IN THE THERMOLYSIS OF INTRAMOLECULARLY COORDINATED ALANES ME2N(CH2)(3)ALX2 - A MATRIX-ISOLATION STUDY

      EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
    28. KLEFFE J; HERMANN K; VAHRSON W; WITTIG B; BRENDEL V
      GENEGENERATOR - A FLEXIBLE ALGORITHM FOR GENE PREDICTION AND ITS APPLICATION TO MAIZE SEQUENCES

      BIOINFORMATICS
    29. SUN Y; JURGOVSKY K; MOLLER P; ALIJAGIC S; DORBIC T; GEORGIEVA J; WITTIG B; SCHADENDORF D
      VACCINATION WITH IL-12 GENE-MODIFIED AUTOLOGOUS MELANOMA-CELLS - PRECLINICAL RESULTS AND A FIRST CLINICAL-PHASE-I STUDY

      Gene therapy
    30. FINKE S; TROJANECK B; LEFTEROVA P; CSIPAI M; WAGNER E; KIRCHEIS R; NEUBAUER A; HUHN D; WITTIG B; SCHMIDTWOLF IGH
      INCREASE OF PROLIFERATION RATE AND ENHANCEMENT OF ANTITUMOR CYTOTOXICITY OF EXPANDED HUMAN CD3(-CELLS BY RECEPTOR-MEDIATED TRANSFECTION WITH THE INTERLEUKIN-7 GENE()CD56(+) IMMUNOLOGICAL EFFECTOR)

      Gene therapy
    31. Blaheta, RA; Leckel, K; Wittig, B; Zenker, D; Oppermann, E; Harder, S; Scholz, M; Weber, S; Schuldes, H; Encke, A; Markus, BH
      Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil

      TRANSPLANT IMMUNOLOGY
    32. HENZE G; BORGMANN A; VONSTACKELBERG A; BAUMGARTEN E; UCHANSKAZIEGLER B; ZIEGLER A; WITTIG B
      IMMUNOTHERAPY OF ACUTE LYMPHOBLASTIC-LEUKEMIA BY VACCINATION WITH AUTOLOGOUS LEUKEMIC-CELLS TRANSFECTED WITH A CDNA EXPRESSION PLASMID CODING FOR AN ALLOGENEIC HLA CLASS-I ANTIGEN COMBINED WITH INTERLEUKIN-2 TREATMENT

      Journal of molecular medicine
    33. Heide, I; Sokoll, AC; Henz, BM; Nagel, S; Kreissig, K; Grutzkau, A; Grabbe, J; Wittig, B; Neubauer, A
      Regulation and possible function of axl expression in immature human mast cells

      ANNALS OF HEMATOLOGY
    34. MOLLER P; WITTIG B; SCHADENDORF D
      INTRATUMORAL ADOPTIVE IMMUNOTHERAPY WITH TUMOR-INFILTRATING LYMPHOCYTES(TIL) IN A MELANOMA PATIENT LEADING TO REGRESSION OF LOCAL TUMOR MASS - A CASE-REPORT

      Anticancer research
    35. WITTIG B; SCHWARZLER C; FOHR N; GUNTHERT U; ZOLLER M
      CUTTING EDGE - CURATIVE TREATMENT OF AN EXPERIMENTALLY-INDUCED COLITIS BY A CD44 VARIANT V7-SPECIFIC ANTIBODY

      The Journal of immunology (1950)
    36. BLAHETA RA; HAILER NP; BRUDE N; WITTIG B; OPPERMANN E; LECKEL K; HARDER S; SCHOLZ M; WEBER S; ENCKE A; MARKUS BH
      NOVEL MODE OF ACTION OF THE CALCIUM-ANTAGONIST MIBEFRADIL (RO-40-5967) - POTENT IMMUNOSUPPRESSION BY INHIBITION OF T-CELL INFILTRATION THROUGH ALLOGENEIC ENDOTHELIUM

      Immunology
    37. KAISER A; WOLFBREITINGER M; ALBERS A; DORBIC T; WITTIG B; RIECKEN EO; ROSEWICZ S
      RETINOIC ACID RECEPTOR GAMMA(1) EXPRESSION DETERMINES RETINOID SENSITIVITY IN PANCREATIC-CARCINOMA CELLS

      Gastroenterology
    38. WIMMERS KK; PONSUKSILI S; VALLEZARATE A; HORST P; WITTIG B
      EVALUATION OF OLIGONUCLEOTIDE PROBES FOR SIMPLE TANDEM REPEATS (STR) TO PRODUCE INFORMATIVE DNA FINGERPRINTS OF THE CHICKEN

      British Poultry Science
    39. Moller, P; Sun, Y; Dorbic, T; Alijagic, S; Makki, A; Jurgovsky, K; Schroff, M; Henz, BM; Wittig, B; Schadendorf, D
      Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study

      BRITISH JOURNAL OF CANCER
    40. SCHMIDT M; NAGEL S; PROBA J; THIEDE C; RITTER M; WARING JF; ROSENBAUER F; HUHN D; WITTIG B; HORAK I; NEUBAUER A
      LACK OF INTERFERON CONSENSUS SEQUENCE BINDING-PROTEIN (ICSBP) TRANSCRIPTS IN HUMAN MYELOID LEUKEMIAS

      Blood
    41. NEUBAUER A; BURCHERT A; MAIWALD C; GRUSS HJ; SERKE S; HUHN D; WITTIG B; LIU E
      RECENT PROGRESS ON THE ROLE OF AXL, A RECEPTOR TYROSINE KINASE, IN MALIGNANT TRANSFORMATION OF MYELOID LEUKEMIAS

      Leukemia & lymphoma
    42. WIMMERS K; PONSUKSILI S; VALLEZARATE A; HORST P; WITTIG B
      ASSESSMENT OF PARENTAL GENOMIC PROPORTIONS IN CROSSBRED CHICKENS BY DNA FINGERPRINTS

      Journal of animal breeding and genetics
    43. GUNTHERT U; SCHWARZLER C; WITTIG B; STAUDER R; BLOEM A; SMADJAJOFFE F; ZOLLER M
      FUNCTIONAL INVOLVEMENT OF CD44, A FAMILY OF CELL-ADHESION MOLECULES, IN IMMUNE-RESPONSES, TUMOR PROGRESSION, AND HEMATOPOIESIS

      Cancer gene therapy
    44. ALBERS A; DORBIC T; WITTIG B
      A NEW PROCEDURE EXTENDS THE BALLISTOMAGNETIC VECTOR SYSTEM FOR EFFICIENT GENE-TRANSFER IN NONADHERENT CELL-TYPES

      Cancer gene therapy
    45. KALKBRENNER F; SCHROFF M; DEGTIAR VE; DIPPEL E; WITTIG B; SCHULTZ G
      SPECIFICITY OF THE RECEPTOR-G-PROTEIN INTERACTION - ASSIGNING FUNCTIONS TO G-PROTEIN SUBUNITS BY THE ANTISENSE TECHNIQUE

      Nucleosides & nucleotides
    46. WANNER R; ZHANG J; DORBIC T; MISCHKE D; HENZ BM; WITTIG B; ROSENBACH T
      THE PROMOTER OF THE HACAT KERATINOCYTE DIFFERENTIATION-RELATED GENE KERATIN-4 CONTAINS A FUNCTIONAL AP-2 BINDING-SITE

      Archives of dermatological research
    47. WOLFL S; WITTIG B; DORBIC T; RICH A
      IDENTIFICATION OF PROCESSES THAT INFLUENCE NEGATIVE SUPERCOILING IN THE HUMAN C-MYC GENE

      Biochimica et biophysica acta, N. Gene structure and expression
    48. WITTIG B; SEITER S; FOGER N; SCHWARZLER C; GUNTHERT U; ZOLLER M
      FUNCTIONAL-ACTIVITY OF MURINE CD44 VARIANT ISOFORMS IN ALLERGIC AND DELAYED-TYPE HYPERSENSITIVITY

      Immunology letters
    49. WANNER R; ZHANG J; WITTIG B; KOLDE G; ROSENBACH T
      RETINOIC ACID DECREASES THE NUMBER OF DESMOSOMES IN HACAT KERATINOCYTES BY REDUCTION OF DESMOSOMAL CADHERINS TRANSCRIPT LEVELS

      Journal of investigative dermatology
    50. KONIG S; SCHMIDT M; ALFKEN J; HOPPE G; NAGEL S; HORAK I; LEVI BZ; NEUBAUER A; WITTIG B
      A POSSIBLE ROLE OF INTERFERON CONSENSUS SEQUENCE BINDING-PROTEIN (ICSBP) IN REGULATING MHC CLASS-II EXPRESSION THROUGH CLASS-II TRANSACTIVATOR (CIITA)

      Blood
    51. SCHMIDT M; NAGEL S; PROBA J; HOCHHAUS A; WARING JF; ROSENBAUER F; EHNINGER G; HUHN D; WITTIG B; HEHLMANN R; HORAK I; NEUBAUER A
      LACK OF INTERFERON CONSENSUS SEQUENCE BINDING-PROTEIN (ICSBP) TRANSCRIPTS IN HUMAN MYELOID LEUKEMIAS AND INDUCTION BY INTERFERON-ALPHA

      Blood
    52. SCHADENDORF D; HENZ BM; WITTIG B
      INTERLEUKIN-7 TRIALS FOR MELANOMA TREATMENT

      Molecular medicine today
    53. NEUBAUER A; THIEDE C; HUHN D; WITTIG B
      P53 AND INDUCTION OF APOPTOSIS AS A TARGET FOR ANTICANCER THERAPY

      Leukemia
    54. THIEDE C; BAYERDORFFER E; BLASCZYK R; WITTIG B; NEUBAUER A
      SIMPLE AND SENSITIVE DETECTION OF MUTATIONS IN THE RAS PROTOONCOGENESUSING PNA-MEDIATED PCR CLAMPING

      Nucleic acids research
    55. KLEFFE J; HERMANN K; VAHRSON W; WITTIG B; BRENDEL V
      LOGITLINEAR MODELS FOR THE PREDICTION OF SPLICE SITES IN PLANT PRE-MESSENGER-RNA SEQUENCES

      Nucleic acids research
    56. VAHRSON W; HERMANN K; KLEFFE J; WITTIG B
      OBJECT-ORIENTED SEQUENCE-ANALYSIS - SCL-A C++ CLASS LIBRARY

      Computer applications in the biosciences
    57. KALKBRENNER F; DIPPEL E; WITTIG B; SCHULTZ G
      SPECIFICITY OF INTERACTION BETWEEN RECEPTOR AND G-PROTEIN - USE OF ANTISENSE TECHNIQUES TO RELATE G-PROTEIN SUBUNITS TO FUNCTION

      Biochimica et biophysica acta. Molecular cell research
    58. DIPPEL E; KALKBRENNER F; WITTIG B; SCHULTZ G
      A HETEROTRIMERIC G-PROTEIN COMPLEX COUPLES THE MUSCARINIC M1 RECEPTORTO PHOSPHOLIPASE C-BETA

      Proceedings of the National Academy of Sciences of the United Statesof America
    59. MULLER V; TAKEYA M; BRENDEL S; WITTIG B; RICH A
      Z-DNA-FORMING SITES WITHIN THE HUMAN BETA-GLOBIN GENE-CLUSTER

      Proceedings of the National Academy of Sciences of the United Statesof America
    60. SCHADENDORF D; SUN Y; MOLLER H; MAKKI A; DORBIC T; WITTIG B; HENZ BM; MOLLER P
      IL-7-GENE-TRANSFER INTO AUTOLOGOUS MELANOMA-CELLS FOR VACCINATION - APILOT-STUDY IN PATIENTS WITH ADVANCED MELANOMA

      Journal of investigative dermatology
    61. DEGTIAR VE; WITTIG B; SCHULTZ G; KALKBRENNER F
      A SPECIFIC G(0) HETEROTRIMER COUPLES SOMATOSTATIN RECEPTORS TO VOLTAGE-GATED CALCIUM CHANNELS IN RINM5F CELLS

      FEBS letters
    62. FINKE S; TROJANECK B; LEFTEROVA P; CSIPAI M; KRUOPIS S; WAGNER E; KIRCHEIS R; NEUBAUER A; HUHN D; WITTIG B; SCHMIDTWOLF IGH
      ENHANCEMENT OF ANTITUMOR CYTOTOXICITY OF HUMAN IMMUNOLOGICAL EFFECTOR-CELLS BY TRANSFECTION WITH THE INTERLEUKIN-7 GENE

      Blood
    63. KLEFFE J; HERMANN K; GUNIA W; VAHRSON W; WITTIG B
      DNASTAT - A PASCAL UNIT FOR THE STATISTICAL-ANALYSIS OF DNA AND PROTEIN SEQUENCES

      Computer applications in the biosciences
    64. KALKBRENNER F; DEGTIAR VE; SCHENKER M; BRENDEL S; ZOBEL A; HESCHLER J; WITTIG B; SCHULTZ G
      SUBUNIT COMPOSITION OF G(O) PROTEINS FUNCTIONALLY COUPLING GALANIN RECEPTORS TO VOLTAGE-GATED CALCIUM CHANNELS

      EMBO journal
    65. WOLFL S; WITTIG B; RICH A
      IDENTIFICATION OF TRANSCRIPTIONALLY INDUCED Z-DNA SEGMENTS IN THE HUMAN C-MYC GENE

      Biochimica et biophysica acta, N. Gene structure and expression
    66. SCHADENDORF D; MOLLER P; DORBIC T; ERTZ S; MOLLER H; SCHROFF M; SCHINAGL M; WITTIG B; CZARNETZKI BM
      VACCINATION OF PATIENTS WITH ADVANCED MELANOMA USING IL-7-GENE TRANSFECTED AUTOLOGOUS MELANOMA-CELLS - FIRST EXPERIENCES

      Journal of investigative dermatology
    67. SCHMITT C; WITTIG B; SCHWAEBLE W; ZUMBUSCHENFELDE KHM; DIPPOLD W
      EXPRESSION OF SOLUBLE AND MEMBRANE-ASSOCIATED COMPLEMENT-INHIBITORS IN CHRONIC INFLAMMATORY BOWEL-DISEASE AND IN NONINFLAMMATORY INTESTINALEPITHELIA

      Gastroenterology
    68. THIEDE C; BAYERDORFFER E; BLASCZYK R; WITTIG B; NEUBAUER A
      SIMPLE AND EFFICIENT DETECTION OF KI-RAS POINT MUTATIONS USING PNA-MEDIATED PCR CLAMPING

      Blood
    69. SCHMIDTWOLF IGH; HUHN D; NEUBAUER A; WITTIG B
      CLINICAL PROTOCOL - INTERLEUKIN-7 GENE-TRANSFER IN PATIENTS WITH METASTATIC COLON-CARCINOMA, RENAL-CELL CARCINOMA, MELANOMA, OR WITH LYMPHOMA

      Human gene therapy
    70. HERR W; SCHWARTING A; WITTIG B; WANITSCHKE R; SCHNITZLER G; WEINERTH J; JOCHUM W; HAKE U; ZUMBUSCHENFELDE KHM
      ENORMOUS HEMANGIOSARCOMA OF THE HEART

      The Clinical investigator
    71. SCHMITT C; SCHWAEBLE W; WITTIG B; ZUMBUSCHENFELDE KHM; DIPPOLD W
      EXPRESSION AND REGULATION OF THE MEMBRANE-ASSOCIATED COMPLEMENT-REGULATORS CD46, CD55 AND CD59 IN GASTROINTESTINAL CELLS

      Gastroenterology
    72. SIMON H; WITTIG B; ZIMMER C
      EFFECT OF NETROPSIN, DISTAMYCIN-A AND CHROMOMYCIN-A(3) ON THE BINDINGAND CLEAVAGE REACTION OF DNA GYRASE

      FEBS letters
    73. GOLLASCH M; KLEUSS C; HESCHELER J; WITTIG B; SCHULTZ G
      G(I2) AND PROTEIN-KINASE-C ARE REQUIRED FOR THYROTROPIN-RELEASING HORMONE-INDUCED STIMULATION OF VOLTAGE-DEPENDENT CA2+ CHANNELS IN RAT PITUITARY GH3 CELLS

      Proceedings of the National Academy of Sciences of the United Statesof America
    74. DIPPOLD W; WITTIG B; SCHWAEBLE W; MAYET W; ZUMBUSCHENFELDE KHM
      EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1, CD54) IN COLONIC EPITHELIAL-CELLS

      Gut
    75. DIPPOLD W; WITTIG B; SCHWABLE W; MAYET W; ZUMBUSCHENFELDE KHM
      EXPRESSION OF INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) IN COLON EPITHELIAL-CELLS

      Gastroenterology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/01/21 alle ore 00:43:56